article thumbnail

Lilly unwraps detailed data showing tirzepatide kept nearly 99% of prediabetic patients diabetes-free over 3 years

Fierce Pharma

Lilly unwraps detailed data showing tirzepatide kept nearly 99% of prediabetic patients diabetes-free over 3 years fkansteiner Wed, 11/13/2024 - 14:37

Patients 317
article thumbnail

ASCO: AstraZeneca's Tagrisso, Imfinzi break new ground in lung cancer—with one standing ovation

Fierce Pharma

A 50% improvement on the time patients could live without disease progression would typically be considered remarkable for a new drug. A 50% improvement on the time patients could live without disease progression would typically be considered remarkable for a new drug. AstraZeneca’s Tagrisso just delivered an 84% improvement. |

Patients 312
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Telehealth, Patient Reviews, and Retailization – 2024 Healthcare Digital Marketing Trends

MedCity News

Here are 5 healthcare marketing trends to pay attention to in 2024. To meet evolving consumer expectations, providers must have a strong digital marketing strategy and user experience online.

Retail 122
article thumbnail

Zocdoc CEO Predicts 5 Ways Patient Behavior Will Change in 2024

MedCity News

Zocdoc Founder and CEO Oliver Kharraz gave five predictions about how patient preferences will evolve in 2024. Some of them include Americans increasingly seeking cash-pay care options and an uptick in patients seeking mental health appointments before and after the presidential election.

Patients 119
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. 📆 November 21, 2024 at 11:00 AM PST, 2:00 PM EST, 7:00 PM GMT

article thumbnail

Eisai, Biogen likely to miss early launch goal for Alzheimer's drug Leqembi

Fierce Pharma

were receiving the amyloid-busting antibody as of Jan. 26, Eisai explained in a third-quarter earnings presentation.

FDA 278
article thumbnail

KnippeRx Transforms Patient Assistance Programs through Technology and Patient-Focused Solutions.

Fierce Pharma

KnippeRx Transforms Patient Assistance Programs through Technology and Patient-Focused Solutions. jpiatt Tue, 11/19/2024 - 10:05

Patients 130